Investors

“At Cenkos, growth companies and investment trusts are our focus and we continue to work with innovative companies to fuel their development, through IPO and beyond.”

Lisa Gordon, Non-Executive Chairman

At a glance

Annual Report 2022

Building long-term relationships, borne out of good client outcomes, lies at the heart of the Firm's ethos.

Julian Morse, Chief Executive Officer

Annual Report 2022

Share price

Business overview

The Company was founded in 2004 and since then has established a successful platform that has been profitable in every year of its existence and delivered strong returns to shareholders. Our prime strategy is to build from these solid foundations to become the pre-eminent UK institutional broker to growth companies and investment funds on a UK market. We aim to achieve this through:

  • Understanding the needs of our clients, enabling us to deliver successful fund raisings and advice through an innovative and entrepreneurial approach;
  • Producing sustainable, diversified and growing income streams;
  • Adding high quality individuals to the teams; and
  • Managing costs and risks carefully.

We strive to deliver shareholder value through earnings growth and attractive cash returns to shareholders.

Information on all share merger of Cenkos Securities PLC and finnCap Group plc

AGM

2023

Annual General Meeting – update 10 May 2023

Please see the link for the AGM results – AGM Results 2023

2022

Annual General Meeting – update 11 May 2022

Please see the link for the AGM results – AGM Results 2022

2021

Annual General Meeting – update 12 May 2021

Please see the link for the AGM results – AGM Results 2021

2020

Annual General Meeting – update 12 June 2020

Please see the link for the AGM results – AGM Results 2020

Regulatory News

RNS Email alerts

Share Price Information

Corporate Governance

QCA Code

The Board recognises the importance of high standards of corporate governance and considers that the Company’s success is enhanced by the imposition of a strong corporate governance framework.

The Board has agreed to apply the Quoted Companies Alliance Corporate Governance Code (“the QCA Code”). The QCA Code is based around 10 broad principles of good corporate governance, aimed at delivering growth, maintaining a dynamic management framework and building trust. The application of the QCA Code requires Cenkos to apply these principles and to publish certain related disclosures. Details concerning the Company’s compliance with the QCA Code are attached here.

Audit Risk and Compliance Committee

The Audit Risk and Compliance Committee, which comprises all the Non-Executive Directors, is chaired by Jeremy Miller. This has the following responsibilities:

  • The monitoring of the Group’s internal control environment;
  • The assessment of the Group’s risks (including financial and market risk in relation to the Group’s market making activities) and plans for mitigating these risks;
  • Review of the Group’s financial statements, reports and announcements and the accounting policies that underlie them, on behalf of the Board;
  • The recommendation to the Board on the appointment and remuneration of the external auditors;
  • The monitoring of the independence of the external auditors and the establishment of a policy for the use of the auditors for non audit work; and
  • The monitoring of the need for an Internal Audit resource.

The Committee meets at least three times year. Other directors, members of staff and the external auditors are invited to attend these meetings, as appropriate. The Committee reports to the Board on the Company’s full and half year results, having examined the accounting policies on which they are based and ensure compliance with relevant accounting standards. In addition, it reviews the scope and results of the external audit, its cost effectiveness and the independence and objectivity of the external auditors.

The Terms of Reference for the Committee can be viewed here

Remuneration Committee

The Remuneration Committee comprises all Non-Executive Directors and is chaired by Andrew Boorman. It determines salary levels, discretionary bonuses and the terms and conditions of service of the Executive Directors. It makes its decisions in consultation with the Chief Executive Officer. No Director plays a part in any decision about their own remuneration. This Committee also reviews bonus and equity arrangements for the Group’s other senior employees and in addition has responsibility for supervising the Cenkos Share Option Scheme and the grant of options under its terms. The remuneration of Non-Executive Directors is fixed by the Board.

The Terms of Reference for the Committee can be viewed here

Nomination Committee

The Nomination Committee, which comprises the Non-Executive Directors, is chaired by Lisa Gordon. It will consider appointments to the Board and is responsible for nominating candidates to fill Board vacancies and for making recommendations on Board composition.

The Terms of Reference for the Committee can be viewed here

Constitutional Documents

Advisers

Bankers
HSBC
Corporate Banking
60 Queen Victoria Street
London
EC4N 4TR

Nominated Adviser
SPARK Advisory Partners Limited
5 St. John’s Lane
London
EC1M 4BH

Solicitors
Simmons & Simmons LLP
CityPoint
1 Ropemaker Street
London
EC2Y 9SS

Travers Smith LLP
10 Snow Hill
London
EC1A 2AL

Broker
Cenkos Securities plc
6.7.8 Tokenhouse Yard
London
EC2R 7AS

Auditor
BDO LLP
150 Aldersgate Street
London
EC1A 4AB

Registrar
Link Asset Services
6th Floor
65 Gresham Street
EC2R 7NQ

Shareholder information

Issued Share Capital: As at 27 June 2023 the total number of ordinary shares of 1p penny each in issue is 56,694,783. Shareholders should use this number as the denominator for calculations by which they will determine if they are required to notify their interest in, or a change to their interests in, the Company’s shares under the FCA’s Disclosure and Transparency Rules.

Individuals and significant holders:

Holder(s)
Percent(%)
Bridger Limited (Stewart family holding)
9.66%
Canaccord Genuity Group Inc
8.36%
Jim Durkin
8.25%
Premier Miton Group plc
4.56%
Nicholas Wells
3.92%

MIFIDPRU 8 Disclosure

AIM Rule 26

Information disclosed in accordance with AIM Rule 26
Full Name:

Cenkos Securities plc

Country of Incorporation:

England and Wales

Registered Company Number:

5210733

Registered Office:

6.7.8 Tokenhouse Yard
London
EC2R 7AS

Listing Date:

31st October 2006

Market:

The Company’s shares are quoted on the Alternative Investment Market (“AIM”) of The London Stock Exchange. The Company is therefore subject to the UK City Code on Takeovers and Mergers.

EPIC:

CNKS

Sector:

General Financial

Activities:

Cenkos Securities is a specialist institutional securities group focused on UK small and mid-cap companies and investment funds. Our principal activities comprise corporate finance, corporate broking, institutional equities, market making.

Shares in issue:

Issued Share Capital: The total number of ordinary shares of 1p penny each in issue is 56,694,783. Shareholders should use this number as the denominator for calculations by which they will determine if they are required to notify their interest in, or a change to their interests in, the Company’s shares under the FCA’s Disclosure and Transparency Rules.

Corporate Governance:

The Board recognises the importance of high standards of corporate governance and considers that the Company’s success is enhanced by the imposition of a strong corporate governance framework.

The Board has agreed to apply the Quoted Companies Alliance Corporate Governance Code (“the QCA Code”). The QCA Code is based around 10 broad principles of good corporate governance, aimed at delivering growth, maintaining a dynamic management framework and building trust. The application of the QCA Code requires Cenkos to apply these principles and to publish certain related disclosures. Details concerning the Company’s compliance with the QCA Code are attached here.

The information on this section is disclosed for the purposes of AIM Rule 26 and was last updated on 27 June 2023.